KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Labcorp Holdings (LH) Payables (2016 - 2025)

Labcorp Holdings (LH) has disclosed Payables for 17 consecutive years, with $840.8 million as the latest value for Q4 2025.

  • Quarterly Payables fell 4.0% to $840.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $840.8 million through Dec 2025, down 4.0% year-over-year, with the annual reading at $840.8 million for FY2025, 4.0% down from the prior year.
  • Payables hit $840.8 million in Q4 2025 for Labcorp Holdings, up from $668.5 million in the prior quarter.
  • In the past five years, Payables ranged from a high of $2.8 billion in Q2 2024 to a low of $601.7 million in Q2 2021.
  • Historically, Payables has averaged $1.2 billion across 5 years, with a median of $858.3 million in 2024.
  • Biggest five-year swings in Payables: surged 174.04% in 2024 and later tumbled 73.77% in 2025.
  • Year by year, Payables stood at $622.8 million in 2021, then soared by 85.21% to $1.2 billion in 2022, then surged by 58.41% to $1.8 billion in 2023, then plummeted by 52.07% to $875.8 million in 2024, then decreased by 4.0% to $840.8 million in 2025.
  • Business Quant data shows Payables for LH at $840.8 million in Q4 2025, $668.5 million in Q3 2025, and $793.0 million in Q2 2025.